Authors
Latest:
Urinary Tract Infections: Opportunities for Clinical and Stewardship PharmacistsThe high volume of antibiotics for urinary tract infections has led to a heavy burden on the health care system, creating an opportunity for antimicrobial stewardship pharmacists to offer recommendations on appropriate therapy, duration of treatment, and unnecessary use of antibiotics.
Latest:
Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing BarriersThis paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Latest:
Teams for the Good of the PatientThe ideal way to treat patients is to make them a member of the team. The Grand-Aides program is an innovative workforce model that successfully uses each member to their maximum capacity.
Latest:
Navigating Patient Home Care During COVID-19 and BeyondHome infusion of specialty medications was an outpatient service offered to patients before the pandemic started; however, with COVID-19, home infusion became more important than ever.
Latest:
Kentucky Bans Pharmacy Gag ClausesImagine a patient walking into your pharmacy with a new prescription from a physician appointment that day. After the technicians process the prescription and the pharmacist has reviewed everything, the patient is ready to be checked out.
Latest:
Venothromboembolism: Treatment Recommendations and Therapeutic OptionsVenothromboembolism has an annual incidence of 1 or 2 cases per 1000 individuals and is the third most common cause of vascular death.
Latest:
Biosimilar Products in Rheumatoid Arthritis: Role of the PharmacistThis Continuing Education activity is supported by an educational grant from Sandoz, Inc.
Latest:
Biologic Management for IBDWith increased specialty medication prescribing, associated costs, and the interest of health systems to establish specialty pharmacies for improved patient care, it is vital to define the pharmacist's role within the patient's health care team.
Latest:
Private-payer Costs for Employees with Treatment-resistant DepressionIndividuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Latest:
What Pharmacists Should Know About the Pitfalls of Step TherapyA ‘fail-first’ policy by the Centers for Medicare and Medicaid Services could be a nightmare for patients with cancer, according to the Community Oncology Alliance.
Latest:
Polypharmacy Interventions Have Potential to Improve Patient OutcomesStudies pertaining to polypharmacy have been increasing over the last decade—yet, interventions aimed to prevent and manage polypharmacy are limited.
Latest:
FDA Approves Pirtobrutinib for Relapsed or Refractory Mantle Cell LymphomaThe FDA has approved pirtobrutinib (Jaypirca) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma following at least 2 lines of systemic therapy, including a Bruton tyrosine kinase inhibitor.
Latest:
Gathering Medical Information: MerckMedicus and MerckSourceMs. Gerhart is manager of pharmacy affairs at Merck & Co Inc.
Latest:
Rise of Oncology Value-Based Care Creates New Imperative for Data TrackingThe rise in value-based reimbursement models has required oncology care providers to assume an unprecedented level of accountability.
Latest:
HRSA Wants to Audit Your 340B Program. Are You Ready? 5 Best Practices for Operating a Compliant 340B ProgramIt's Friday afternoon and your hospital receives an e-mail from the Health Resources and Services Administration, notifying you that your hospital has been selected for a 340B program audit. Are you ready?
Latest:
"American Patients First" Plan Marks a Good First Step: Here's What Should Happen Next to Lower Drug CostsWith American Patients First, the administration is doing its part to improve prescription drug affordability—now it’s time for Congress to do theirs.
Latest:
Impact of Medicaid Preferred Drug List on Long-Acting Opioid UsersAn opioid preferred drug list was not associated with an increase in emergency department visits or hospitalizations in a Medicaid population.
Latest:
The Pharma PharmacistDoes the prospect of continuing lower reimbursement rates, crazy hours, longer phone wait times, and slow and inefficient pharmacy software have you considering a new career?
Latest:
Delivering Evidence-Based Value to Cancer PatientsSpecialty Pharmacy Times spoke with Dr. Neubauer to discuss the intricacies of clinical pathways, including how to reconcile a drug's cost and benefits, the importance of making evidence-based decisions, when to deviate from recommended treatment pathways, and why he thinks all health plans should pay for the routine costs of clinical trials.
Latest:
What Keeps You Up at Night?Our new department focuses on the issues that the industry faces as it is held to very high standards of compliance with minimal guidance. So what are the rules to be in compliance?
Latest:
Impact of Insulin Delivery Systems in Elderly Patients With Type 2 DiabetesThis real-world study suggests that improved clinical outcomes are possible in the difficult-to-treat elderly patients with type 2 diabetes group without affecting healthcare costs, by initiating insulin therapy with a pen device.
Latest:
The Evolution of Pneumococcal Vaccines and Current GuidelinesPharmacists are in an excellent position to educate and counsel patients on current recommendations.
Latest:
Using the Patient Care Process in the Community: Patient-Oriented CareCommunity pharmacists are valuable health care providers given their accessibility and distribution throughout the community, extended hours of operation, and clinical knowledge.
